What are the opening hours?

Monday 9am - 6pm Tuesday 9am - 6pm Wednesday 9am - 6pm Thursday 9am - 6pm Friday 9am - 6pm

Excelra

Home
India
Uppal
Excelra

Excelra's data and analytics solutions empower innovation in life sciences across the value chain from discovery to market.

The Excelra Edge comes from a seamless amalgamation of proprietary curated data assets, deep domain expertise and data science. The company's multifaceted teams harmonize and analyze large volumes of disparate unstructured data using cutting-edge technologies. We galvanize data-driven decisions to unlock operational efficiencies to accelerate drug discovery and development. Over the past 18 years, Excelra has been the preferred data and analytics partner to over 90 global clients including 15 of the top 20 large Pharma companies.

02/12/2025

Can your PDX RNA-seq pipeline separate signal from noise?
Discover how end-to-end demousing reveals high-confidence biomarkers: https://na2.hubs.ly/H02kbDD0

PDX datasets are powerful — but only when human tumor reads are isolated, QC’d, and modeled with precision. With a connected workflow spanning QC and demousing fragmented RNA-seq files became a clear biological story.

This case study shows how a refined pipeline uncovers pathways linked to progression and therapy response.
See how structured data transforms cancer research.

01/12/2025

Did you know? Nearly 40 million people are living with HIV today, each carrying a story of strength, stigma, and the fight for equitable care. Progress starts with understanding the virus at a molecular level and translating that knowledge into better therapies.

At Excelra, we enable this by delivering curated, high-confidence insights that help researchers decode antiviral mechanisms. With GOSTAR™ and its millions of SAR data points, scientists get the connected intelligence needed to accelerate HIV drug discovery.

Together, let’s work toward a future where HIV becomes not just treatable - but preventable, predictable, and ultimately, history.

28/11/2025

Can harmonizing 4,500+ multi-omics samples unlock clearer MoA insights? https://na2.hubs.ly/H02g4Mp0

Fragmented datasets make it hard to understand how a molecule behaves across platforms and disease contexts. Excelra addresses this by building a unified multi-omics asset that:

- Unifies transcriptomic, proteomic & scRNA-seq data
- Preserves biological signal post–batch correction
- Enables biomarker, MoA & competitive insights

The Outcome? A decision-ready data asset that strengthens MoA interpretation, benchmarking, and repurposing assessments.

27/11/2025

Is your omics data being used to its full potential?
Unlock the hidden value in your sequencing and biomarker datasets: https://na2.hubs.ly/H02g4p00

Omics data is expanding rapidly, yet much of it stays underused. Silos, poor metadata, and missing context limit teams from extracting meaningful discovery insights. Our latest whitepaper shows how curated, interoperable omics data can accelerate target identification and biomarker discovery.

Download the whitepaper to see how high-quality omics data can give you a strategic R&D advantage.

26/11/2025

Ever wondered how much scientific insight gets lost when OMICS data lives in scattered silos?
https://na2.hubs.ly/H02dMZb0

Researchers spend weeks fixing genomics and proteomics data instead of uncovering insights. Heterogeneity and missing metadata slow everything down. It’s time to treat OMICS data as a strategic asset. Our latest blog shows how structured, interoperable datasets accelerate discovery.

Read our latest blog to see how OMICS data assets power faster and smarter drug development.

24/11/2025

Upcoming Webinar: From Clinical Data to Decisions — Integrating Clinical Pharmacology with Pharmacometrics Modelling
Register Today: https://na2.hubs.ly/H02bMDt0

Learn how Model-Informed Drug Development (MIDD) and Model-Based Meta-Analysis (MBMA) leverage standardized, analysis-ready datasets to enable confident dose selection, optimized trial design, and stronger regulatory strategy.

December 10, 2025 | 4:30 PM CET | 10:30 AM EST

21/11/2025

Ever wondered how much innovation gets lost when CRO data arrives in scattered formats? Turn chaos into clarity: https://na2.hubs.ly/H0287kY0

Pharma teams spend weeks cleaning CRO data instead of discovering insights. Different file types, missing metadata, and unstructured inputs slow everything down - from research to regulatory readiness.

It’s time to treat CRO data as a strategic asset, not an operational headache. Our latest blog explores how standardisation, automation, and integration can help R&D teams unlock faster, cleaner, and compliant data pipelines.

Dive in to see how leading pharma companies are transforming CRO collaboration into a true competitive advantage.

&D &DInnovation

20/11/2025

We’re excited to welcome Nicolas Goffard to Excelra as our Director, Key Account Management – Europe!

With 25 years of experience across bioinformatics, multi-omics, and commercial strategy, Nicolas brings a unique blend of scientific depth and business leadership. A PhD holder with 30+ publications, he has driven commercial growth and strategic partnerships at Biorelate, Lifebit, DNAnexus, Metabolon, WuXi NextCODE, and more.

At Excelra, he will lead our key account strategy in Europe, strengthening relationships with strategic clients and driving collaborations that accelerate drug discovery and development through data and analytics.

Please join us in welcoming Nicolas to the Excelra family!

19/11/2025

Are fragmented datasets slowing your discovery pipeline?
See how 4,500+ scattered omics samples became actionable insights: https://na2.hubs.ly/H026R3g0

Many R&D workflows have the data — but not the clarity. Disparate transcriptomic, proteomic, and scRNA-seq sources create noise, delays, and overlooked opportunities.

This case study shows how harmonized, FAIR-ready Data Assets transformed that complexity into a connected ecosystem.

Read the full case study and see how structured data accelerates discovery.

18/11/2025

We’re excited to welcome Pramod Chonamkandathil to Excelra as our Vice President, Human Resources!

With over 24 years of experience across IT, Life Sciences, and Analytics, Pramod has led impactful HR transformations and built people-first, high-performing cultures at Mindsprint, Emids Technologies, Optum, and Wipro.

At Excelra, he will lead our global HR function, shaping strategies that empower talent, enhance leadership, and strengthen our culture of growth and collaboration.

Welcome to the Excelra family, Pramod — we’re thrilled to have you on board!

17/11/2025

One Day to Go!
Register now: https://na2.hubs.ly/H020gw40

Join us tomorrow for our live session: “Optimizing Data-Driven Drug Design with GOSTAR™”
Discover how curated SAR data accelerates molecule design, strengthens ADME modeling, and integrates seamlessly with AI/ML-driven workflows.

November 18 | 10:00 AM IST | 03:30 PM AEST | 01:30 PM JST
Don’t miss this opportunity to see data in action!

Address

7th Floor Wing B
Uppal
500039

Opening Hours

Monday	9am - 6pm
Tuesday	9am - 6pm
Wednesday	9am - 6pm
Thursday	9am - 6pm
Friday	9am - 6pm

Telephone

+91 40 6707 3333

Website

https://www.excelra.com/

Alerts

Be the first to know and let us send you an email when Excelra posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Excelra:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Practice
Claim ownership or report listing

Want your practice to be the top-listed Clinic in Uppal?